https://www.marketscreener.com/quote/stock/DICERNA-PHARMACEUTICALS-I-15657740/news/Dicerna-Announces-Two-Targets-Meet-Preclinical-Proof-of-Principle-Criteria-in-Neurodegeneration-and-37001512/?utm_source=telegram&utm_medium=social&utm_campaign=share